The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to ...

In Honeywell International Inc. v. 3G Licensing, S.A., Appeal No. 23-1354, the Federal Circuit held that under the obviousness standard of 35 U.S.C.

Feb 4 (Reuters) - The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' (SUPN.O), opens new tab drug-device combination to treat movement-related symptoms of Parkinson's ...

Calcium homeostasis plays an essential role in maintaining excitation–contraction coupling (ECC) in cardiomyocytes, including calcium release, recapture, and storage. Disruption of calcium homeostasis ...

This study is the first to confirm the superior efficacy and tolerability of the initial use of combination therapy as vs. monotherapy in patients with severe hypertension. In a difficult-to-treat ...

Introduction： The efficacy of blood pressure (BP) reduction of Sacubitril/valsartan has been proved in hypertension patients, yet not in patients with acute ischemic stroke (AIS). We aimed to ...

For present purposes, the claims of the ‘659 Patent called for a pharmaceutical combination comprising valsartan and sacubitril “administered in combination” in about a 1:1 ratio.

Novartis AG NVS, a Swiss pharma giant, is scheduled to report fourth-quarter 2024 and full-year results on Jan. 31, 2025. The company’s earnings surpassed estimates in each of the trailing four ...

On Tuesday, the Kansas City Chiefs revealed a first look at the uniforms they will wear in Super Bowl LIX, which features an iconic patch to commemorate the team’s third-consecutive appearance in the ...